A New Era in Cardiometabolic Management: Unlocking the Potential of Artificial Intelligence for Improved Patient Outcomes
المؤلف | Nashwan, Abdulqadir J. |
تاريخ الإتاحة | 2023-11-05T06:14:28Z |
تاريخ النشر | 2023 |
اسم المنشور | Endocrine Practice |
المصدر | Scopus |
الرقم المعياري الدولي للكتاب | 1530891X |
الملخص | Cardiometabolic disorders are a range of health conditions such as diabetes, obesity, and cardiovascular diseases that are a major concern for global health. These disorders affect millions of people and are a leading cause of morbidity and mortality. As of 2021, an estimated 463 million people worldwide have diabetes, with the number expected to rise to 700 million by 2045. Obesity affects over 650 million adults globally, significantly increasing the risk of cardiometabolic complications. Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 18 million deaths annually. These staggering statistics emphasize the urgent need for effective prevention, diagnosis, and treatment strategies to address the growing burden of cardiometabolic disorders on healthcare systems and societies worldwide. The use of artificial intelligence (AI) in managing cardiometabolic disorders has the potential to transform prevention, diagnosis, and treatment, ultimately leading to better patient outcomes |
راعي المشروع | A.J.N.: Conceptualization, Literature search, Manuscript preparation, Manuscript preparation, final editing. All author/s read and approved the final manuscript. |
اللغة | en |
الناشر | Elsevier |
الموضوع | Cardiometabolic Management Artificial Intelligence Patient Outcomes |
النوع | Other |
الصفحات | 743-745 |
رقم العدد | 9 |
رقم المجلد | 29 |
تحقق من خيارات الوصول
الملفات في هذه التسجيلة
الملفات | الحجم | الصيغة | العرض |
---|---|---|---|
لا توجد ملفات لها صلة بهذه التسجيلة. |
هذه التسجيلة تظهر في المجموعات التالية
-
الصحة العامة [425 items ]